Webull Singapore’s Investors Now Have Access to SGX-Listed Products – Fintech Singapore

Webull Securities (Singapore) Pte Ltd, a subsidiary of the US-based Webull Financial LLC, has announced its new offering of SGX-listed products and securities to retail investors. Webull Singapore officially launched in May 2022, pushing its global app downloads to 40 million globally.

This allows customers of Webull Singapore to invest in a broad array of investment options including stocks, REITs, DLCs, and ETFs listed on the Singapore Exchange (SGX).

The addition of these SGX-listed products means that Webull’s platform now provides access to over 700 SGX-listed entities, alongside its existing range of over 15,000 US stocks and options, and more than 3,000 securities from Hong Kong, Mainland China A-shares.

The platform also offers a selection of up to 400 mutual funds from various fund houses, and wealth management tools like Moneybull and Regular Savings Plan to assist investors in managing and growing their assets.

This expansion into SGX-listed securities is aimed at enabling investors to diversify their portfolios and manage risks according to their investment preferences. It offers the opportunity for stable, long-term investments in dividend stocks, blue-chip companies, REITs, and ETFs listed on the SGX.

Webull added that it will continue to explore and introduce additional features and products for investors.

Bernard Teo

Bernard Teo, Head of Asia-Pacific, Webull Corporation and CEO of Webull Singapore said,

“By providing access to key financial markets in Mainland China, Hong Kong, the US, and Singapore, we hope to offer our clients in Singapore enhanced flexibility across their investment portfolios, ultimately empowering investors to build a globally diverse portfolio.”

• SEO Powered Content & PR Distribution. Get Amplified Today.
• PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
• PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
• PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
• PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
• Source: https://fintechnews.sg/84455/wealthtech/webull-singapores-investors-now-have-access-to-sgx-listed-products/